FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

326121004: Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3674337017 Dinoprostone 3 mg vaginal tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3674338010 Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
46714501000001117 Dinoprostone 3mg pessaries en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Is a Product containing dinoprostone in vaginal dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has active ingredient Prostaglandin PGE>2< false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has active ingredient Prostaglandin E>1< false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has active ingredient Dinoprostone false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has active ingredient Posterior pituitary hormone false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has active ingredient Alprostadil false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has manufactured dose form Vaginal dose form false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has manufactured dose form Conventional release vaginal tablet false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has basis of strength substance Dinoprostone true Inferred relationship Existential restriction modifier 1
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has presentation strength numerator value 3 false Inferred relationship Existential restriction modifier 1
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has precise active ingredient Dinoprostone true Inferred relationship Existential restriction modifier 1
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Is a Product containing only dinoprostone in vaginal dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Plays role Oxytocic therapeutic role true Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Is a Dinoprostone true Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has manufactured dose form Vaginal dose form true Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has manufactured dose form Conventional release vaginal tablet false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has active ingredient Dinoprostone false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route pessary.vaginal ontology form and route true Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Vaginal route true Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has manufactured dose form Pessary false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has manufactured dose form Conventional release vaginal tablet false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has manufactured dose form Conventional release vaginal tablet false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has manufactured dose form Pessary false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has manufactured dose form Pessary false Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has specific active ingredient Dinoprostone true Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has dispensed dose form Pessary true Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has manufactured dose form Pessary false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Dinoprostone 3mg vaginal tablet - product Is a False Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) Is a True Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Inferred relationship Existential restriction modifier
Dinoprostone 3mg vaginal tablets 8 pessary Is pack of False Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Inferred relationship Existential restriction modifier
Dinoprostone 3mg vaginal tablets 8 pessary Has VMP True Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start